STOCK TITAN

Insiders at CRWV (NASDAQ: CRWV) plan Rule 144 sale amid large 10b5-1 trades

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

CRWV has a Rule 144 notice covering the planned sale of 1,000 common shares, with an aggregate market value of $89,950, through Morgan Stanley Smith Barney on the NASDAQ around February 9, 2026. The filing lists 386,401,201 common shares outstanding for context.

The seller acquired these 1,000 shares as founders’ shares on February 25, 2019. The notice also details extensive prior Rule 10b5-1 sales over the past three months by Brannin McBee, related trusts, and other entities, including individual transactions such as 102,835 shares sold for more than $8.1 million and 257,733 shares sold for about $19.6 million.

Positive

  • None.

Negative

  • None.

Insights

Planned CRWV Rule 144 sale is small, but follows large prior insider 10b5-1 sales.

This notice covers a proposed sale of 1,000 CRWV common shares with an aggregate market value of 89950.00, to be executed via Morgan Stanley Smith Barney on NASDAQ. The shares are founders’ shares originally acquired on February 25, 2019, so this reflects disposition of long-held equity.

The filing’s three‑month history shows sizable Rule 10b5‑1 sales by Brannin McBee and related trusts, with single transactions such as 102,835 common shares for proceeds above 8000000.00 and 257,733 shares for proceeds above 19000000.00. These are pre‑arranged plan trades but indicate meaningful ongoing selling activity by affiliated holders.

The form also includes the standard representation that the selling person does not know material adverse, nonpublic information about CRWV’s current or prospective operations. Future company filings and ownership disclosures will provide additional context on remaining holdings and any continuation of these Rule 10b5‑1 sales programs.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does the CRWV Rule 144 filing disclose about planned share sales?

The filing discloses a planned sale of 1,000 CRWV common shares with an aggregate market value of $89,950, to be executed through Morgan Stanley Smith Barney on NASDAQ around February 9, 2026, under Rule 144 resale provisions for restricted or control securities.

How many CRWV shares are outstanding in this Rule 144 notice?

The notice states that 386,401,201 CRWV common shares are outstanding. This figure provides context for the relative size of the 1,000-share planned Rule 144 sale and helps investors gauge how small this specific proposed transaction is against the company’s total share base.

How and when were the 1,000 CRWV shares in this filing originally acquired?

The 1,000 CRWV common shares covered by this notice were acquired as founders’ shares on February 25, 2019, directly from the issuer. The filing indicates the acquisition date and labels the transaction as “Founders Shares,” with the same date shown for payment and “N/A” as the nature of payment.

What prior 10b5-1 sales related to CRWV are listed over the past three months?

The document lists numerous Rule 10b5‑1 sales by Brannin McBee and related trusts, including transactions such as 102,835 CRWV common shares sold on December 29, 2025, and a 257,733‑share sale by a Non‑Affiliate Donee on December 1, 2025, each generating multi‑million‑dollar gross proceeds.

Who is involved in the prior CRWV 10b5-1 sales mentioned in the filing?

Entities involved include Brannin McBee, Brannin J. McBee 2022 Irrevocable Trust, CANIS MAJOR TRUST, several CANIS MAJOR and CANIS MINOR family trusts and GRATs, and a Non‑Affiliate Donee. Each entry specifies the seller name, date, amount of CRWV common shares sold, and gross proceeds.

What representation does the seller make about CRWV information in this Rule 144 notice?

The seller represents that they do not know any material adverse information about CRWV’s current or prospective operations that has not been publicly disclosed. If relying on a Rule 10b5‑1 trading plan, that representation also applies as of the plan adoption or instruction date.
CoreWeave, Inc.

NASDAQ:CRWV

CRWV Rankings

CRWV Latest News

CRWV Latest SEC Filings

CRWV Stock Data

46.89B
313.25M
24.91%
55.56%
5.94%
Software - Infrastructure
Services-prepackaged Software
Link
United States
LIVINGSTON